58
Views
12
CrossRef citations to date
0
Altmetric
Miscellaneous

Allosteric modulation of G-protein-coupled receptors

, &
Pages 1889-1904 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pier Giovanni Baraldi, Allan R Moorman, Mojgan Aghazadeh Tabrizi, MariaGiovanna Pavani & Romeo Romagnoli. (2004) Allosteric modulators for the A1 adenosine receptor. Expert Opinion on Therapeutic Patents 14:1, pages 71-79.
Read now
Vincent Mutel. (2002) Therapeutic potential of non-competitive, subtype-selective metabotropic glutamate receptor ligands. Expert Opinion on Therapeutic Patents 12:12, pages 1845-1852.
Read now

Articles from other publishers (10)

Romeo Romagnoli, Pier Giovanni Baraldi, Allan R Moorman, Pier Andrea Borea & Katia Varani. (2015) Current status of A 1 adenosine receptor allosteric enhancers . Future Medicinal Chemistry 7:10, pages 1247-1259.
Crossref
Zhiyi Yu, Elisabeth Klaasse, Laura H. Heitman & Adriaan P. IJzerman. (2014) Allosteric modulators of the hERG K+ channel. Toxicology and Applied Pharmacology 274:1, pages 78-86.
Crossref
M. Alcolea Palafox, P. Posada-Moreno, A. L. Villarino-Marín, C. Martinez-Rincon, I. Ortuño-Soriano & I. Zaragoza-García. (2010) DFT calculation of four new potential agents muscarinic of bispyridinium type: structure, synthesis, biological activity, hydration, and relations with the potents W84 and DUO-3O. Journal of Computer-Aided Molecular Design 25:2, pages 145-161.
Crossref
Richard L. Wood, Brendan J. Young-Dixon, Abhrajeet Roy, Bryant C. Gay, Rodney L. Johnson & Elizabeth A. Amin. (2010) Evaluation of density functionals, SCC-DFTB, neglect of diatomic differential overlap (NDDO) models and molecular mechanics methods for prolyl-leucyl-glycinamide (PLG) and structural analogs. Journal of Molecular Structure: THEOCHEM 944:1-3, pages 76-82.
Crossref
Ulf Sürig, Klaudia Gaal, Evi Kostenis, Christian Tränkle, Klaus Mohr & Ulrike Holzgrabe. (2006) Muscarinic Allosteric Modulators: Atypical Structure‐Activity‐Relationships in Bispyridinium‐type Compounds. Archiv der Pharmazie 339:4, pages 207-212.
Crossref
Elisabeth C. Klaasse, Gijs van den Hout, Sophie F. Roerink, Willem J. de Grip, Ad P. IJzerman & Margot W. Beukers. (2005) Allosteric modulators affect the internalization of human adenosine A1 receptors. European Journal of Pharmacology 522:1-3, pages 1-8.
Crossref
Jürgen Teichgräber & Ulrike Holzgrabe. (2003) A novel class of allosteric modulators of the muscarinic M2 acetylcholine receptor: terphenyl derivatives. Tetrahedron 59:44, pages 8697-8703.
Crossref
Christian Tränkle, Oliver Weyand, Uta Voigtländer, Anita Mynett, Sebastian Lazareno, Nigel J. M. Birdsall & Klaus Mohr. (2003) Interactions of Orthosteric and Allosteric Ligands with [ 3 H]Dimethyl-W84 at the Common Allosteric Site of Muscarinic M 2 Receptors . Molecular Pharmacology 64:1, pages 180-190.
Crossref
Tjerk J.H Bueters, Herman P.M van Helden, Meindert Danhof & Ad P IJzerman. (2002) Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release. European Journal of Pharmacology 454:2-3, pages 177-182.
Crossref
Derek T. Chalmers & Dominic P. Behan. (2002) The use of constitutively active GPCRs in drug discovery and functional genomics. Nature Reviews Drug Discovery 1:8, pages 599-608.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.